Dr. Abdalhamid F. Al Harash, FACP, MD

Dr. Al Harash practices at SoCal Arthritis in Chino, California.

Dr. Al Harash's NPI, 1962790618, was assigned on July 15, 2011. Dr. Al Harash graduated from Damascus University Faculty of Medicine in 2010. Dr. Al Harash holds California license C167575.

Dr. Al Harash's primary practice is SoCal Arthritis, at 13768 Roswell Ave Ste 100, Chino, CA 91710-1401. The practice phone is (909) 342-7892.

Dr. Al Harash's primary practice is SoCal Arthritis in Chino, California. Dr. Al Harash is also affiliated with Pomona Valley Hospital Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Al Harash to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al Harash practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Al Harash's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Al Harash is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Al Harash's licenses on file in 7 states: California, Michigan, Florida, Wisconsin, Pennsylvania, Indiana and Kentucky.

Dmand AI lists arteritis, arthritis, bursitis, fibromyalgia and chronic pain, fluid in a joint, gout, immune deficiency disease and joint arthropathy among the conditions Dr. Al Harash treats.

CMS data shows 2,575 Medicare services from Dr. Al Harash across 12 procedure codes in 2024, for 260 Medicare patients. Medicare paid $94,429 for them. Every service was in an office.

CMS counts 260 Medicare patients who saw Dr. Al Harash in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have arthritis, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Al Harash's median patient age at 60, with 80% women.

In 2024, Dr. Al Harash wrote 2,340 Medicare Part D claims for 442 patients. 79% of them were for generic drugs. CMS names the drug for 2,101 of them, across 46 drugs with 11 or more claims each, at $2,631,032 in total drug cost. In 2023, CMS named 1,457 claims across 38 drugs.

Dr. Al Harash accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Al Harash as offering telehealth.

Dmand AI links 4 papers to Dr. Al Harash, published from 2017 to 2021. Dr. Al Harash has published most often in Case Rep Rheumatol. Dr. Al Harash's most frequent co-authors are Michael J. Lucke, MD, Swati Arora and Adam L. Dore, DO.

CMS Open Payments shows 581 general payments to Dr. Al Harash from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Amgen Inc. paid the most, $3,633.

Dr. Al Harash graduated from Damascus University Faculty of Medicine in 2010.

Dr. Al Harash is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.